news aktuell GmbH

Majority of European Vapers Are Former Smokers: E-Cigarettes Offer Significant Harm Reduction Potential

28.5.2025 12:06:43 CEST | news aktuell GmbH | Pressmeddelande

Dela

Brussels, 28 May 2025 — In the lead-up to World No Tobacco Day 2025 on 31 May, the Independent European Vape Alliance (IEVA) highlights compelling evidence that the majority of e-cigarette users in Europe are former smokers. This underscores the important role that vaping can play in tobacco harm reduction and as a tool to support smoking cessation.

According to the Special Eurobarometer survey, only 3% of current e-cigarette users in the EU are individuals who have never smoked. [1] A separate study published in the Journal of Epidemiology (2023) further confirms this: among over 12,000 participants across 12 EU countries, only 0.4% of never smokers reported ever trying an e-cigarette. [2] This confirms that vaping is not attracting non-smokers at a meaningful level, but rather serving as a tool for adult smokers seeking alternatives.

The health benefits of switching from combustible cigarettes to e-cigarettes are significant. According to a recent Cochrane review, nicotine-containing e-cigarettes are more effective than traditional nicotine replacement therapies (NRTs) in helping individuals quit smoking. The review found that for every 100 people using nicotine e-cigarettes to stop smoking, 8 to 10 might successfully quit, compared to only 6 of 100 using NRTs. [3]

Dr. Nicola Lindson, University Research Lecturer at the University of Oxford and Managing Editor of the Cochrane Tobacco Addiction Group, stated: “E-cigarettes do not burn tobacco; and as such they do not expose users to the same complex mix of chemicals that cause diseases in people smoking conventional cigarettes. E-cigarettes are not risk-free, and shouldn’t be used by people who don’t smoke or aren’t at risk of smoking. However, evidence shows that nicotine e-cigarettes carry only a small fraction of the risk of smoking.” [4]

Despite this, public perception often misrepresents the relative risks of vaping. A study conducted in six European countries, involving individuals who had smoked at least 100 cigarettes in their lifetime and smoked at least monthly, found that 62% perceived e-cigarettes as equally or more harmful than cigarettes, while only 28% perceived them as less harmful. [5]

This widespread misperception persists despite the scientific consensus that vaping is substantially less harmful than smoking. In fact, Public Health England has concluded that e-cigarettes are at least 95% less harmful than combustible tobacco products — a finding supported by multiple independent reviews conducted since 2015. [6]

IEVA urges policymakers to recognize the potential of e-cigarettes in reducing smoking rates across Europe. By providing accurate information and integrating vaping into public health strategies, governments can empower smokers to make informed choices that could lead to significant health improvements.

Millions of smokers in Europe deserve to know that switching to vaping can significantly reduce their health risks,” said Dustin Dahlmann, President of IEVA. “Policymakers have a responsibility to communicate this harm reduction potential clearly and objectively.”

__________________________

Sources:

[1] “Attitudes of Europeans towards tobacco and electronic cigarettes”, Eurobarometer 2017 Link

[2] “Electronic Cigarette Use in 12 European Countries: Results From the TackSHS Survey” Journal of Epidemiology 2023 Link

[3] “Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose?” Cochrane Review 2025 Link

[4] “Latest Cochrane Review finds high certainty evidence that nicotine e-cigarettes are more effective than traditional nicotine-replacement therapy (NRT) in helping people quit smoking” Cochrane Review 2022  Link

[5] “European adult smokers’ perceptions of the harmfulness of e-cigarettes relative to combustible cigarettes” European Journal of Public Health 2020 Link

[6] “PHE publishes independent expert e-cigarettes evidence review” Press release 2018 Link

 

 

 

 

 

 

Kontakter

Press contact:

Independent European Vape Alliance (IEVA)

President: Dustin Dahlmann

Press coordinator: Philip Drögemüller

Phone: +32 (2) 791 7759

E-Mail: p.droegemueller@eurovape.eu

Web: www.eurovape.eu

About IEVA

The Independent European Vape Alliance (IEVA) is the only pan-European association aimed at uniting national associations, companies, manufacturers and wholesalers in the vaping industry and providing them with responsible representation at the European level. IEVA’s founding principle is to contribute to harm reduction and public health. E-cigarettes have a significant positive impact and should be recognized as a harm reduction tool because vaping is not smoking.

 

Följ news aktuell GmbH

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från news aktuell GmbH

Grünenthal licenses exclusive South Korean rights to Qutenza® to BCWorld Pharm5.3.2026 08:40:44 CET | Press Release

Aachen, Germany & Yeoju, South Korea, 5 March 2026 – Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and diversifying its pain management portfolio through global open innovation partnerships, announced today that they have entered into a definitive agreement whereby BCWP will have the exclusive South Korean rights to Qutenza®, a topical, non-systemic, non-opioid patch treatment. In Europe, the product is indicated for the management of peripheral neuropathic pain. Under the agreement, BCWP will be responsible for obtaining marketing authorisation for Qutenza® in South Korea. Upon approval, the company will market and distribute the product. Grünenthal will receive an upfront payment in addition to regulatory and sales-related milestone payments. “We are executing on a dedicated strategy to bring Qutenza® into the Asia-Pacific region to facilitate greater access to non-opioid treatment opt

Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:07:51 CET | Press Release

Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.

Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press Release

The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence. In a time when everything seems to begin to dissolve, when disorientation prevails more than ever and when one is searching for something to hold on to, certainty can be found in uncertainty. Lara's authentic interpretation, with her multi-faceted voice, conveys confidence in finding a way for oneself and others. In the faceless, noisy crowd, where glances are not returned and touches are not felt, one is pulled away by an invisible hand. You are on your own, but somewhere there is a light and a hope that guides you when the fog lifts and you find yourself in the certainty of meeting someone who “can read my mind and my soul.” Invisibly connected, across time and space, this path is open.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye